 |
2-(7-ethoxy-4-(3-fluorophenyl)-1-oxophthalazin-2(1H)-yl)-N-methyl-N-(2-methylbenzo[d]oxazol-6-yl)acetamide |
|---|---|
| Trade Name | |
| Orphan Indication | Cystic fibrosis |
| USA Market Approval | USA |
| USA Designation Date | 2015-05-13 00:00:00 |
| Sponsor | Flatley Discovery Lab;529 Main Street, Suite 115;Charlestown, Massachusetts, 02129 |
Related Access Program